DE69532492D1 - Verfahren zur Reinigung von rekombinantem menschlichem Serumalbumin - Google Patents

Verfahren zur Reinigung von rekombinantem menschlichem Serumalbumin

Info

Publication number
DE69532492D1
DE69532492D1 DE69532492T DE69532492T DE69532492D1 DE 69532492 D1 DE69532492 D1 DE 69532492D1 DE 69532492 T DE69532492 T DE 69532492T DE 69532492 T DE69532492 T DE 69532492T DE 69532492 D1 DE69532492 D1 DE 69532492D1
Authority
DE
Germany
Prior art keywords
purification
serum albumin
human serum
recombinant human
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69532492T
Other languages
English (en)
Other versions
DE69532492T2 (de
Inventor
Munehiro Noda
Akinori Sumi
Takao Ohmura
Kazumasa Yokoyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Application granted granted Critical
Publication of DE69532492D1 publication Critical patent/DE69532492D1/de
Publication of DE69532492T2 publication Critical patent/DE69532492T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69532492T 1994-08-31 1995-08-30 Verfahren zur Reinigung von rekombinantem menschlichem Serumalbumin Expired - Lifetime DE69532492T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20770494 1994-08-31
JP20770494 1994-08-31

Publications (2)

Publication Number Publication Date
DE69532492D1 true DE69532492D1 (de) 2004-03-04
DE69532492T2 DE69532492T2 (de) 2004-12-02

Family

ID=16544190

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69532492T Expired - Lifetime DE69532492T2 (de) 1994-08-31 1995-08-30 Verfahren zur Reinigung von rekombinantem menschlichem Serumalbumin

Country Status (9)

Country Link
US (2) US5962649A (de)
EP (1) EP0699687B1 (de)
KR (1) KR100392021B1 (de)
CN (2) CN1080301C (de)
CA (1) CA2157219C (de)
DE (1) DE69532492T2 (de)
DK (1) DK0699687T3 (de)
ES (1) ES2211889T3 (de)
TW (1) TW363065B (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
CA2157219C (en) * 1994-08-31 2010-10-05 Munehiro Noda Process for purifying recombinant human serum albumin
WO1997031947A1 (en) * 1996-02-29 1997-09-04 Delta Biotechnology Limited High purity albumin production process
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
EP0947581A4 (de) * 1996-08-08 2004-07-28 Mitsubishi Pharma Corp Kulturmedium und seine verwendung.
IL137649A (en) * 1998-02-18 2004-08-31 Genentech Inc Method of adsorption chromatography
US7279001B2 (en) * 1998-11-06 2007-10-09 Neomend, Inc. Systems, methods, and compositions for achieving closure of vascular puncture sites
US6899889B1 (en) * 1998-11-06 2005-05-31 Neomend, Inc. Biocompatible material composition adaptable to diverse therapeutic indications
US6830756B2 (en) * 1998-11-06 2004-12-14 Neomend, Inc. Systems, methods, and compositions for achieving closure of vascular puncture sites
US7351249B2 (en) * 1998-11-06 2008-04-01 Neomend, Inc. Systems, methods, and compositions for achieving closure of suture sites
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
EP1284287A4 (de) * 2000-05-10 2004-10-13 Mitsubishi Pharma Corp Verfahren zur herstellung eines virusvektors
US6787636B1 (en) 2000-07-14 2004-09-07 New Century Pharmaceuticals, Inc. Modified serum albumin with reduced affinity for nickel and copper
EP1175931A1 (de) * 2000-07-25 2002-01-30 Computer Cell Culture Center S.A. Betriebsintegration eines Hochzelldichtebioreaktors mit ultra-schnelle on-line Weiterverarbeiting
US7276605B2 (en) 2001-02-01 2007-10-02 Roche Diagnostics Operations, Inc. Method for producing recombinant trypsin
JP2002265383A (ja) * 2001-03-14 2002-09-18 Mitsubishi Pharma Corp インターフェロンα注射用液状製剤
ES2298378T3 (es) 2001-06-28 2008-05-16 Novo Nordisk A/S Formulacion estable de glp-1 modificado.
ITBO20010426A1 (it) 2001-07-06 2003-01-06 Alfa Wassermann Spa Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
KR20030007186A (ko) * 2001-07-17 2003-01-23 미쯔이카가쿠 가부시기가이샤 광 양이온성 경화가능 수지 조성물 및 그 용도
US7351800B2 (en) 2002-02-28 2008-04-01 Nipro Corporation Stabilized albumin preparations
SE526227C2 (sv) 2002-05-15 2005-08-02 North China Pharmaceutical Group Metod för rening av rekombinant humant serumalbumin
AU2003281982A1 (en) * 2002-11-26 2004-06-18 Novo Nordisk A/S Process for purifying a fermentation-derived product
US20040217055A1 (en) * 2003-03-12 2004-11-04 Elmar Kraus Use of recombinant albumin in dialysis after liver failure
ES2380437T3 (es) 2003-06-03 2012-05-11 Novo Nordisk A/S Composiciones farmacéuticas de péptido GLP-1 estabilizadas
JP2007524592A (ja) 2003-06-03 2007-08-30 ノボ・ノルデイスク・エー／エス 安定化された薬学的ペプチド組成物
RU2421238C2 (ru) 2003-11-20 2011-06-20 Ново Нордиск А/С Пептидная композиция, содержащая пропиленгликоль, являющаяся оптимальной для изготовления и применения в инъекционных устройствах
JP2005245269A (ja) * 2004-03-03 2005-09-15 Nipro Corp 血清アルブミン多量体を含む遺伝子組換え型蛋白質
CN1956998B (zh) * 2004-04-23 2012-12-12 康久有限责任公司 用于纯化白蛋白结合物的方法
DK1765866T3 (en) 2004-06-07 2014-03-24 Therapure Biopharma Inc ISOLATION OF plasma or serum protein
CN100374560C (zh) * 2004-08-27 2008-03-12 富岩 高效表达人血清白蛋白酵母菌株的构建及发酵纯化工艺
WO2006024631A2 (en) 2004-08-31 2006-03-09 Novo Nordisk A/S Use of tris(hydroxymethyl) aminomethane for the stabilization of peptides, polypeptides and proteins
AU2005303777B2 (en) 2004-11-12 2010-12-16 Novo Nordisk A/S Stable formulations of insulinotropic peptides
CN1854306B (zh) * 2005-04-29 2011-07-27 华北制药集团新药研究开发有限责任公司 发酵生产重组人血清白蛋白hsa的方法
IL169230A (en) 2005-06-16 2012-03-29 Plasan Sasa Agricultural Cooperative Soc Ltd Ballistic armor
WO2007063129A2 (en) * 2005-12-02 2007-06-07 Novozymes A/S Insolation of peptides , polypeptides and proteins
JP4935242B2 (ja) * 2006-08-24 2012-05-23 ニプロ株式会社 脂肪酸を含有するｓ−ニトロソタンパク質とその製法
US20100267933A1 (en) 2006-12-21 2010-10-21 Moya Wilson Purification of proteins
US8569464B2 (en) 2006-12-21 2013-10-29 Emd Millipore Corporation Purification of proteins
BRPI0806601A2 (pt) * 2007-01-15 2011-09-06 Upfront Chromatography As produção de biocombustìvel e proteìna a partir de um material bruto
DK2370561T3 (da) 2008-12-16 2019-10-21 Emd Millipore Corp Omrøringstankreaktor og fremgangsmåde
CA2752729A1 (en) 2009-02-20 2010-08-26 Ventria Bioscience Cell culture media containing combinations of proteins
CN102190722B (zh) * 2010-03-16 2014-03-26 上海欣瑞特生物医药技术有限公司 一种纯化重组人血白蛋白的方法
EP3597671B1 (de) 2010-05-17 2022-09-21 EMD Millipore Corporation Stimulusreaktive polymere zur aufreinigung von biomolekülen
CN102532254B (zh) * 2010-12-24 2015-06-24 武汉禾元生物科技股份有限公司 一种从水稻种子中分离纯化重组人血清白蛋白的方法
WO2012177792A2 (en) 2011-06-24 2012-12-27 Sequenom, Inc. Methods and processes for non-invasive assessment of a genetic variation
US9984198B2 (en) 2011-10-06 2018-05-29 Sequenom, Inc. Reducing sequence read count error in assessment of complex genetic variations
US10424394B2 (en) 2011-10-06 2019-09-24 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10196681B2 (en) 2011-10-06 2019-02-05 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US20140242588A1 (en) 2011-10-06 2014-08-28 Sequenom, Inc Methods and processes for non-invasive assessment of genetic variations
US9367663B2 (en) 2011-10-06 2016-06-14 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP2805280B1 (de) 2012-01-20 2022-10-05 Sequenom, Inc. Diagnostische verfahren zur evaluierung von versuchsbedingungen
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10482994B2 (en) 2012-10-04 2019-11-19 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
EP4187543A1 (de) 2013-04-03 2023-05-31 Sequenom, Inc. Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
CN105555968B (zh) 2013-05-24 2020-10-23 塞昆纳姆股份有限公司 遗传变异的非侵入性评估方法和过程
IL283586B2 (en) 2013-06-21 2023-11-01 Sequenom Inc Methods and processes for non-invasive evaluation of genetic variations
ES2968644T3 (es) 2013-10-04 2024-05-13 Sequenom Inc Métodos y procedimientos para la evaluación no invasiva de variaciones genéticas
EP3495496B1 (de) 2013-10-07 2020-11-25 Sequenom, Inc. Verfahren und prozesse zur nichtinvasiven beurteilung chromosomaler veränderungen
US20160034640A1 (en) 2014-07-30 2016-02-04 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
SI3240798T1 (sl) 2015-01-01 2020-07-31 Shilpa Medicare Limited Nov postopek za učinkovito čiščenje humanega serumskega albumina
WO2018022890A1 (en) 2016-07-27 2018-02-01 Sequenom, Inc. Genetic copy number alteration classifications
EP3574424A1 (de) 2017-01-24 2019-12-04 Sequenom, Inc. Verfahren und prozesse zur beurteilung genetischer variationen
PE20211202A1 (es) 2017-08-24 2021-07-05 Novo Nordisk As Composiciones de glp-1 y sus usos
WO2021144476A1 (en) 2020-02-18 2021-07-22 Novo Nordisk A/S Pharmaceutical formulations
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
KR20230060524A (ko) 2020-12-08 2023-05-04 통화 안레이트 바이오파마슈티컬 컴퍼니 리미티드 재조합 단백질의 정제 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR570916A (de) 1923-09-20 1924-05-09
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
KR830002718A (ko) 1980-04-22 1983-05-30 가와무라 요시부미 피라졸 유도체의 제조법
US4665192A (en) * 1984-03-19 1987-05-12 The Rockefeller University 2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole
FR2649991B2 (fr) * 1988-08-05 1994-03-04 Rhone Poulenc Sante Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
WO1993001207A1 (en) * 1991-07-12 1993-01-21 Gist-Brocades N.V. Process for the purification of serum albumin
JPH07102147B2 (ja) * 1992-03-16 1995-11-08 株式会社ミドリ十字 ヒト血清アルブミンの着色抑制方法
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
CA2157219C (en) * 1994-08-31 2010-10-05 Munehiro Noda Process for purifying recombinant human serum albumin

Also Published As

Publication number Publication date
CA2157219A1 (en) 1996-03-01
DE69532492T2 (de) 2004-12-02
US5962649A (en) 1999-10-05
TW363065B (en) 1999-07-01
KR100392021B1 (ko) 2003-11-01
EP0699687A2 (de) 1996-03-06
EP0699687B1 (de) 2004-01-28
CN1127299A (zh) 1996-07-24
CN1080301C (zh) 2002-03-06
DK0699687T3 (da) 2004-04-26
KR960007612A (ko) 1996-03-22
US6617133B1 (en) 2003-09-09
ES2211889T3 (es) 2004-07-16
CA2157219C (en) 2010-10-05
CN1364643A (zh) 2002-08-21
EP0699687A3 (de) 1996-12-18

Similar Documents

Publication Publication Date Title
DE69532492D1 (de) Verfahren zur Reinigung von rekombinantem menschlichem Serumalbumin
DE69331507D1 (de) Verfahren zur Reinigung von menschlichem, rekombinantem Serumalbumin
DE59505881D1 (de) Verfahren zur Herstellung von Xerogelen
DE69826705D1 (de) Verfahren zur dermalen verabreichung von polypeptiden
DE59501145D1 (de) Verfahren zur Herstellung von Cycloolefincopolymeren
DE69005959D1 (de) Verfahren zur Reinigung von menschlichem Serum-Albumin.
DE69531843D1 (de) Verfahren zur Herstellung von Dimethyldecandisäure
DE69502374D1 (de) Verfahren zur Herstellung von Methylcyanoacrylat
DE59812758D1 (de) Verfahren zur herstellung von 8-methoxy-chinoloncarbonsäuren
DE69528008T2 (de) Verfahren zur Herstellung von optisch-aktiven 4-Hydroxy-2-Ketoglutarsäuren
DE69531308D1 (de) Verfahren zur Herstellung von gereinigten papillomavirus Proteinen
DE69124638D1 (de) Verfahren zur Reinigung von Alkoxysilanen
DE69331992T2 (de) Verfahren zur hochaufreinigung von menschlichem serumalbumin
DE69220113D1 (de) Verfahren zur Herstellung von menschlichem Serum Albumin
DE69531424D1 (de) Verfahren zur Reinigung von Halosilanen
DE69512495D1 (de) Verfahren zur Herstellung von Chinolin-2-yl-benzoesäure
DE69816622D1 (de) Verfahren zur Steigerung der Expression von Fremdproteinen
DE69505335T2 (de) Verfahren zur Reinigung von Methacrylsäure
DE59505811D1 (de) Verfahren zur Herstellung von Methylchlorsilanen
DE69329841D1 (de) Verfahren zur Unterdrückung der Koloration von menschlichem Serum-Albumin
DE69431097D1 (de) Verfahren zur Herstellung von humanem Serumalbumin
DE69530176T2 (de) Verfahren zur Herstellung von Protein
DE69501535D1 (de) Verfahren zur Reinigung von Difluormethan
DE69516038D1 (de) Verfahren zur Restaurierung von Kunstwerken
DE69408843D1 (de) Verfahren zur Reinigung von Acifluorfen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition